Related Experiment Videos

[Antibiotic resistance of Pseudomonas aeruginosa strains isolated from patients with infected burns]

Antibiotiki
|August 1, 1980
PubMed

Insights

Pseudomonas aeruginosa (P. aeruginosa) strains from burn infections show high resistance to many antibiotics. Gentamicin demonstrated the most activity, offering potential treatment options for infected burns.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Pseudomonas aeruginosa (P. aeruginosa) is a common opportunistic pathogen.
  • Infected burns present a significant clinical challenge due to potential P. aeruginosa colonization and infection.
  • Antibiotic resistance in P. aeruginosa complicates treatment strategies.

Purpose of the Study:

  • To evaluate the in vitro sensitivity of P. aeruginosa strains isolated from infected burn patients to a panel of 15 antimicrobial drugs.
  • To identify antibiotics with significant activity against these resistant strains for potential therapeutic use.

Main Methods:

  • Agar dilution method was employed to test the susceptibility of 248 P. aeruginosa isolates.
  • Isolates were obtained from patients with infected burns.
  • Minimum inhibitory concentrations (MICs) were determined for 15 different drugs.

Main Results:

  • All 248 strains exhibited resistance to polymyxin M, ceporin, erythromycin, and oleandomycin.
  • High resistance rates were observed for streptomycin, monomycin, ampicillin, and rifampicin.
  • Gentamicin was the most effective antibiotic, inhibiting 87% of P. aeruginosa strains at therapeutic doses.
  • Moderate resistance was noted for carbenicillin, morphocycline, vibramycin, kanamycin, tetraolean, and tetracycline.

Conclusions:

  • P. aeruginosa strains from infected burns display extensive multi-drug resistance.
  • Gentamicin is recommended as a primary therapeutic option for parenteral and local treatment of P. aeruginosa-infected burns.
  • Further surveillance of antibiotic resistance patterns is crucial for effective clinical management.

Related Concept Videos